Showing 1 - 10 of 1,901
of non-price competition. Home attachment reduces the intensity of tax competition, but generates a strategic …
Persistent link: https://www.econbiz.de/10013316737
This paper studies R&D investment decisions of a firm facing the threat of new technology entry and subject to technical uncertainty. We distinguish four scenarios: inevitable entry, entry deterrence, entry blockade, and non-credible entry threat. The entry threat stimulates the incumbent to...
Persistent link: https://www.econbiz.de/10010261128
price than a fully competitive duopoly. Being able to define the degree of knowledge exchange when creating a research joint …This paper presents a dynamic model of a competitive R&D and production duopoly subject to knowledge spillovers. Two …
Persistent link: https://www.econbiz.de/10010261135
equilibrium disclosure strategies for any knowledge spillover in a simple Cournot duopoly model, and illustrate the results …
Persistent link: https://www.econbiz.de/10010261185
Recent empirical studies suggest a need for a flexible patent regime responding to industry characteristics. In practice, sector-specific modifications of patent strength already exist but lack theoretical foundation. This paper intends to make up for this neglect by scrutinizing in what...
Persistent link: https://www.econbiz.de/10010270491
applies more generally to duopoly pricing. …
Persistent link: https://www.econbiz.de/10010273874
This paper develops a two-country, dynamic general equilibrium model with innovation contests to study the impact of globalization on the skill premium and fully-endogenous growth. Higher quality products are endogenously discovered through stochastic and sequential global innovation contests in...
Persistent link: https://www.econbiz.de/10014262950
experiment from Norway, which in 2003 introduced a reference price (RP) system called "index pricing" for a sub-sample of off …-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … group, with the effect being stronger for brand-names. We also identify a negative cross-price effect on therapeutic …
Persistent link: https://www.econbiz.de/10013316907
more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …
Persistent link: https://www.econbiz.de/10014080046
HPV vaccination rates while keeping innovation incentives. We estimate the global patent buyout price as the present … Merck with extraordinarily strong price setting power …
Persistent link: https://www.econbiz.de/10012825394